title: Compound haploinsufficiencies of Ebf1 and Runx1 genes impede B cell lineage progression.
abstract: Early B cell factor (EBF)1 is essential for B lineage specification. Previously, we demonstrated the synergistic activation of Cd79a (mb-1) genes by EBF1 and its functional partner, RUNX1. Here, we identified consequences of Ebf1 haploinsufficiency together with haploinsufficiency of Runx1 genes in mice. Although numbers of "committed" pro-B cells were maintained in Ebf1(+/-)Runx1(+/-) (ER(het)) mice, activation of B cell-specific gene transcription was depressed in these cells. Expression of genes encoding Aiolos, kappa0 sterile transcripts, CD2 and CD25 were reduced and delayed in ER(het) pro-B cells, whereas surface expression of BP-1 was increased on late pro-B cells in ER(het) mice. Late pre-B and immature and mature B cells were decreased in the bone marrow of Ebf1(+/-) (E(het)) mice and were nearly absent in ER(het) mice. Although we did not observe significant effects of haploinsuficiencies on IgH or Igkappa rearrangements, a relative lack of Iglambda rearrangements was detected in E(het) and ER(het) pre-B cells. Together, these observations suggest that B cell lineage progression is impaired at multiple stages in the bone marrow of E(het) and ER(het) mice. Furthermore, enforced expression of EBF1 and RUNX1 in terminally differentiated plasmacytoma cells activated multiple early B cell-specific genes synergistically. Collectively, these studies illuminate the effects of reduced Ebf1 dosage and the compounding effects of reduced Runx1 dosage. Our data confirm and extend the importance of EBF1 in regulating target genes and Ig gene rearrangements necessary for B cell lineage specification, developmental progression, and homeostasis.
authors.affiliation: Integrated Department of Immunology, National Jewish Health, Denver, CO 80206, USA.
authors.forename: Kara
authors.initials: K
authors.lastname: Lukin
authors.forename: Scott
authors.initials: S
authors.lastname: Fields
authors.forename: Desiree
authors.initials: D
authors.lastname: Lopez
authors.forename: Marie
authors.initials: M
authors.lastname: Cherrier
authors.forename: Kristina
authors.initials: K
authors.lastname: Ternyak
authors.forename: Julita
authors.initials: J
authors.lastname: Ramírez
authors.forename: Ann J
authors.initials: AJ
authors.lastname: Feeney
authors.forename: James
authors.initials: J
authors.lastname: Hagman
mesh_terms: D000818:Animals; D001402:B-Lymphocytes / Q000166:cytology* / Q000378:metabolism; D018801:CD2 Antigens / Q000378:metabolism; D002454:Cell Differentiation / Q000235:genetics*; D019070:Cell Lineage / Q000235:genetics*; D050676:Core Binding Factor Alpha 2 Subunit / Q000378:metabolism*; D017931:DNA Primers / Q000235:genetics; D005434:Flow Cytometry; D018628:Gene Dosage / Q000235:genetics*; D018507:Gene Expression Regulation, Developmental / Q000235:genetics*; D051740:Ikaros Transcription Factor; D053645:Interleukin-2 Receptor alpha Subunit / Q000378:metabolism; D051379:Mice; D020133:Reverse Transcriptase Polymerase Chain Reaction; D015534:Trans-Activators / Q000378:metabolism*
chemical_list: D018801:CD2 Antigens; D050676:Core Binding Factor Alpha 2 Subunit; D017931:DNA Primers; C489921:Ebf1 protein, mouse; C491396:Ikzf3 protein, mouse; D053645:Interleukin-2 Receptor alpha Subunit; C493726:Runx1 protein, mouse; D015534:Trans-Activators; D051740:Ikaros Transcription Factor
references.citation: Proc Natl Acad Sci U S A. 2009 Jan 13;106(2):552-7
references.pmid: 19122139
references.citation: Blood Cells Mol Dis. 2009 Jul-Aug;43(1):12-9
references.pmid: 19269865
references.citation: EMBO J. 2007 Feb 21;26(4):1163-75
references.pmid: 17290219
references.citation: J Immunol. 2008 Jul 1;181(1):383-92
references.pmid: 18566404
references.citation: Genes Dev. 2005 Aug 1;19(15):1779-86
references.pmid: 16027168
references.citation: Nat Immunol. 2004 Oct;5(10):1069-77
references.pmid: 15361869
references.citation: Blood. 2005 Jul 15;106(2):494-504
references.pmid: 15784726
references.citation: Nat Immunol. 2008 Aug;9(8):927-36
references.pmid: 18568028
references.citation: Mol Cell. 2000 Feb;5(2):343-53
references.pmid: 10882075
references.citation: Proc Natl Acad Sci U S A. 1996 Apr 16;93(8):3444-9
references.pmid: 8622955
references.citation: Proc Natl Acad Sci U S A. 2009 Jul 7;106(27):11258-63
references.pmid: 19549820
references.citation: Nature. 1995 Jul 20;376(6537):263-7
references.pmid: 7542362
references.citation: Oncogene. 1998 Nov 5;17(18):2287-93
references.pmid: 9811459
references.citation: EMBO J. 2003 Sep 15;22(18):4759-69
references.pmid: 12970188
references.citation: Dev Cell. 2004 Oct;7(4):607-17
references.pmid: 15469848
references.citation: Immunity. 2002 May;16(5):661-72
references.pmid: 12049718
references.citation: Int Immunol. 1994 Aug;6(8):1257-64
references.pmid: 7526894
references.citation: Genes Dev. 1994 May 1;8(9):1043-57
references.pmid: 7926786
references.citation: Nature. 2007 Apr 12;446(7137):758-64
references.pmid: 17344859
references.citation: Immunity. 2006 Mar;24(3):269-81
references.pmid: 16546096
references.citation: J Exp Med. 2005 Mar 21;201(6):971-9
references.pmid: 15767371
references.citation: J Exp Med. 2001 Sep 3;194(5):645-56
references.pmid: 11535632
references.citation: EMBO J. 1997 Apr 15;16(8):2004-13
references.pmid: 9155026
references.citation: Stem Cells. 2004;22(2):158-68
references.pmid: 14990855
references.citation: Blood. 2008 Feb 1;111(3):1543-51
references.pmid: 17940206
references.citation: Mol Immunol. 2008 Aug;45(14):3786-96
references.pmid: 18606452
references.citation: Immunity. 2007 Jun;26(6):703-14
references.pmid: 17582343
references.citation: Mol Cell Biol. 2002 Dec;22(24):8539-51
references.pmid: 12446773
references.citation: Immunity. 2007 Mar;26(3):335-44
references.pmid: 17363301
references.citation: Immunity. 2007 Jun;26(6):715-25
references.pmid: 17582344
references.citation: J Immunol. 1990 Apr 15;144(8):2925-30
references.pmid: 1691222
references.citation: Curr Opin Hematol. 2001 Jul;8(4):192-6
references.pmid: 11561154
references.citation: Mol Cell Biol. 2007 Jan;27(2):579-94
references.pmid: 17101802
references.citation: Immunity. 1999 Jul;11(1):21-31
references.pmid: 10435576
references.citation: J Exp Med. 2004 Jun 21;199(12):1689-700
references.pmid: 15210745
references.citation: Trends Immunol. 2005 Sep;26(9):455-61
references.pmid: 16027038
references.citation: Nature. 1986 Jun 5-11;321(6070):616-8
references.pmid: 3086746
references.citation: Cell. 1996 Jan 26;84(2):321-30
references.pmid: 8565077
references.citation: Nat Immunol. 2008 Feb;9(2):203-15
references.pmid: 18176567
references.citation: J Exp Med. 2005 Apr 18;201(8):1197-203
references.pmid: 15837809
references.citation: Cell. 2002 Nov 27;111(5):621-33
references.pmid: 12464175
references.citation: Nat Genet. 1999 Oct;23(2):166-75
references.pmid: 10508512